{"url":"https://lda.gov/api/v1/filings/a0d87146-33cd-41af-a538-5dfca5aa5b0d/","filing_uuid":"a0d87146-33cd-41af-a538-5dfca5aa5b0d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a0d87146-33cd-41af-a538-5dfca5aa5b0d/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"HWM III","dt_posted":"2025-04-13T13:39:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"24 Dockside Lane #500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Key Largo","registrant_state":"FL","registrant_zip":"33037","registrant":{"id":401105070,"url":"https://lda.gov/api/v1/registrants/401105070/","house_registrant_id":null,"name":"GOVERNMENT COUNSEL, LLC","description":"Government advisory firm","address_1":"24 Dockside Lane #500","address_2":null,"address_3":null,"address_4":null,"city":"Key Largo","state":"FL","state_display":"Florida","zip":"33037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"H.W. MENN","contact_telephone":"+1 202-235-5613","dt_updated":"2026-07-20T11:52:00.384413-04:00"},"client":{"id":203130,"url":"https://lda.gov/api/v1/clients/203130/","client_id":12,"name":"APOTEX CORPORATION","general_description":"Generic pharmaceutical manufacturer","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-01"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.","foreign_entity_issues":"Apotex Inc. exercises management over Apotex Corp. but holds no equity in, and provides no funding of Apotex Corp. lobbying activities. Apotex Inc.'s interest in Apotex Corp. lobbying activities is limited to Apotex Corp.'s financial success in the US market.","lobbyists":[{"lobbyist":{"id":71402,"prefix":null,"prefix_display":null,"first_name":"HENRY","nickname":null,"middle_name":"W","last_name":"MENN","suffix":"iii","suffix_display":"III"},"covered_position":"Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"APOTEX INC.","contribution":"0.00","ownership_percentage":"0.00","address":"150 Signet Drive","city":"Toronto","state":"ON","state_display":"Ontario","country":"CA","country_display":"Canada","ppb_city":"Toronto","ppb_state":"ON","ppb_state_display":"Ontario","ppb_country":"CA","ppb_country_display":"Canada"}],"affiliated_organizations":[]}